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clinical accepted plans for both automated TPS was 
drastically reduced to less than ten minutes.  
For the two stereotactic sites evaluated, target coverage and 
OARs doses differences were not clinically relevant between 
Auto-Planning and manually optimized plans.  
The encouraging results of automatic planning shows that 
highly consistent treatment plans for complex cases can be 
achieved with an automated planning process. 
 
SP-0312  
Automated treatment plan generation - the Milan 
experience 
A. Fogliata
1Humanitas Research Hospital, Department of Radiation 
Oncology, Rozzano-Milan, Italy 
1 
 
A knowledge based planning process, named RapidPlan, has 
been recently implemented into the Varian Eclipse treatment 
planning system. The goal of the engine is to generate 
patient tailored and personalized objectives to input in the 
optimization process for IMRT or VMAT inverse planning. Data 
from previously generated high quality plans are used to 
estimate DVH ranges where the specific DVH of a structure 
will most likely land according to the prior plans knowledge. 
Estimate-based optimisation objectives are hence generated. 
A complete pre-clinical preparation have been established 
before the clinical implementation of RapidPlan and the 
configured specific models. The anatomical sites and 
pathologies chosen for the first models generation in Milan 
were Head and Neck, and Breast. For the first site the choice 
was driven by the complexity of the planning phase due to 
the anatomy and critical structures; the breast was chosen 
since, beside of its planning complexity, almost one third of 
our patient population presents breast cancer. For each of 
the two chosen sites the process of the model generation 
included different phases. Initially a set of about 100 patients 
per site, having quite spread anatomical characteristics (as, 
for example, the breast size) while excluding extreme 
anatomies, was selected. The selected plans were all clinical 
plans of high quality, for VMAT (RapidArc) delivery. Those 
plans were used to train the model for the extraction of the 
parameters, based on prinicipal component analysis methods 
and regression models, needed to estimate the DVH for any 
new patient. The training results were analysed to evaluate 
possible outliers and their eventual exclusion from the 
model. Finally the validation process was followed on another 
group of patients to assess the model reliability and usability. 
From this last phase improvements in the plan quality when 
using RapidPlan was assessed. Once the two models were 
evaluated, a number of head and neck and breast cases were 
selected for the pre-clinical trial. The planners used to plan 
without RapidPlan were asked to produce plans using the 
knowledge based planning models. Two kind of evaluations 
were felt interesting: on one side the plan quality, for which 
the same cases were asked to be planned without RapidPlan 
by the same planner, and on the other side the time required 
to obtain such plans. The results were very promising, both 
on the plan quality, and especially on planning time. We are 
ready to move to the clinical daily use of the automated 
treatment plan generation. 
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Aim: Treatment plan generation in radiotherapy is commonly 
a trial-and-error procedure in which a dosimetrist tries to 
steer the treatment planning system (TPS) towards an 
acceptable patient dose distribution. For a single patient, 
this process may take up to several days of workload. The 
quality of the final treatment plan is dependent on the skills 
and experience of the dosimetrist, and on allotted time. In 
addition, for the treating physician it is extremely difficult to 
assess whether the generated plan is indeed optimal 
considering the unique anatomy of the individual patient. At 
Erasmus MC, systems for fully automated plan generation 
have been developed to obtain plans of consistent high 
quality, with a minimum of workload. This presentation will 
focus on their clinical implementation and applications.  
 
Materials and methods: An IMRT or VMAT plan is generated 
fully automatically (i.e., without human interface) by the 
clinical TPS (Monaco, Elekta AB), based on a patient-specific 
template. The patient-specific template is automatically 
extracted from a plan generated with Erasmus-iCycle, our in-
house developed pre-optimizer for lexicographic multi-
criterial plan generation (Med Phys. 2012; 39: 951-963). For 
individual patients of a treatment site (e.g., prostate), 
automatic plan generation in Erasmus-iCycle is based on a 
fixed ‘wishlist’ with hard constraints and treatment 
objectives with assigned priorities. The higher the priority of 
an objective, the higher the chance that the planning aim 
will be achieved, or even superseded. All plans generated 
with Erasmus-iCycle are Pareto optimal. In case of IMRT, the 
system can be used for integrated beam profile optimization 
and (non-coplanar) beam angle selection. Site-specific 
wishlists are a priori generated in an iterative procedure 
with updates of the wishlist in every iteration step, based on 
physicians’ feedback on the quality of plans generated with 
the current wishlist version. Also for patients treated at a 
Cyberknife, either with the variable aperture collimator (Iris) 
or MLC, the clinical TPS (Multiplan, Accuray Inc.) can be used 
to automatically generate a deliverable plan, based on a pre-
optimization with Erasmus-iCycle. 
 
Results: Currently, automatic treatment planning is clinically 
used for more than 30% of patients that are treated in our 
department with curative intent. It is routinely applied for 
prostate, head and neck, lung and cervical cancer patients 
treated at a linac. In a prospective clinical study for head and 
neck cancer patients, treating radiation oncologists selected 
the Erasmus-iCycle/Monaco plan in 97% of cases rather than 
the plan generated with Monaco by trial-and-error (IJROBP 
2013; 85: 866-72). For a group of 41 lung cancer patients, 
clinically acceptable VMAT plans could be generated fully 
automatically in 85% of cases; in all those cases plan quality 
was superior compared to manually generated Monaco plans, 
due to a better PTV coverage, dose conformality, and/or 
sparing of lungs, heart and oesophagus. For plans that were 
initially not clinically acceptable, it took a dosimetrist little 
hands-on time (<10 minutes) to modify them to a clinically 
acceptable plan. In 44 dual-arc VMAT Erasmus-iCycle/Monaco 
plans for cervical cancer treatment small bowel V45Gy was 
reduced by on average 20% (p<0.001) when compared to the 
plans that were manually generated by an expert Monaco 
user, spending 3 hours on average. Differences in bladder, 
rectal and sigmoid doses were insignificant. For 30 prostate 
cancer patients, differences between Erasmus-iCycle/Monaco 
VMAT plans and VMAT plans manually generated by an expert 
planner with up to 4 hours planning hands-on time, were 
statistically insignificant (IJROBP 2014; 88(5): 1175-9). 
Attempts to use acceptable, automatically generated plans 
as a starting point for manual generation of further improved 
plans have been unsuccessful. For prostate SBRT, clinically 
deliverable Cyberknife plans that were automatically 
generated with Erasmus-iCycle/Multiplan showed a better 
rectum sparing and a reduced low-medium dose bath 
compared to automatically generated VMAT plans with the 
same CTV-PTV margin.  
 
Conclusion: In our department, automatic plan generation 
based on Erasmus-iCycle is currently widely used, showing a 
consistent high plan quality and a vast reduction in planning 
workload. Extension to new target sites (breast, liver, 
lymphoma, spine, vestibular schwannoma) is being 
investigated. In addition, the use of automated planning for 
intensity modulated proton therapy is being explored, making 
objective plan comparison with other modalities possible. 
